Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
MBX Biosciences, Inc. has 4 disclosed suppliers and 0 disclosed customers. Each one is named in an SEC filing, either MBX Biosciences, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
No filing we have read names a customer of MBX Biosciences, Inc.. Customers appear here when MBX Biosciences, Inc. names them, or when a company names MBX Biosciences, Inc. as a supplier in its own annual report.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“Dr. DiMarchi is a current consultant to the Company, as well as the principal investigator under our research agreement with the Trustees of Indiana University, under which we retain intellectual property developed on our behalf by Dr. DiMarchi, but the consulting agreement and research agreement are both terminable by either party.”
FILING10-K0001193125-26-103121cik 0001776111
“In June 2020, we entered into an Exclusive License Agreement with Indiana University Research and Technology Corporation ("IURTC"), a non-profit corporation organized under the laws of the State of Indiana, represented by The Trustees of Indiana University ("IU") pursuant to which we have been granted an exclusive, royalty-bearing license to certain IURTC patent rights ("the Licensed Intellectual Property") developed by Dr. DiMarchi and other collaborators to further scientific research, for new product development, and for other applications in public interest, such license, the IURTC License Agreement.”
FILING10-K0001193125-26-103121cik 0001776111
“The Shares were sold pursuant to the Company's Open Market Sale Agreement SM with Jefferies, LLC dated November 6, 2025 and a shelf registration statement on Form S-3 (File No. 333-291308) previously filed by us and declared effective by the SEC in December 2025.”
FILING10-K0001193125-26-103121cik 0001776111
“Dr. DiMarchi is a current consultant to the Company, as well as the principal investigator under our research agreement with the Trustees of Indiana University, under which we retain intellectual property developed on our behalf by Dr. DiMarchi, but the consulting agreement and research agreement are both terminable by either party.”
FILING10-K0001193125-26-103121cik 0001776111
Watchlist prices, news filtered to it, and its next report on your desk.
MBX (MBX Biosciences, Inc.) has 4 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: JEF −2.47%, in financials.
MBX Biosciences, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 60.84 · gapped below the open, then crossed back over prior close. High/low 61.81 at 4:00 pm ET, 58.59 at 10:45 am ET.